Latest News Mar 17, 2026 Esperion to Present Two New Analyses from CLEAR Outcomes Clinical Trial at the American College of Cardiology 2026 Annual Scientific Session Mar 16, 2026 Esperion’s Bempedoic Acid Receives Multiple Class 1 Recommendations in 2026 ACC/AHA Multisociety Guideline for Management of Dyslipidemia View All News Latest Quarterly Earnings Results Corporate Presentation ESPR Company Presentation - March 2026 6.6 MB Investor Events Upcoming Events More events are coming soon. Past Events Mar 11, 2026 8:25 AM EDT The 2026 Citizens Life Sciences Conference Mar 10, 2026 8:00 AM EDT Fourth Quarter and Full Year 2025 Financial Results View All Events
Mar 17, 2026 Esperion to Present Two New Analyses from CLEAR Outcomes Clinical Trial at the American College of Cardiology 2026 Annual Scientific Session
Mar 16, 2026 Esperion’s Bempedoic Acid Receives Multiple Class 1 Recommendations in 2026 ACC/AHA Multisociety Guideline for Management of Dyslipidemia